Companies: 10,795·Total market cap: $144.5T
Olema Pharmaceuticals, Inc.

Olema Pharmaceuticals, Inc.

OLMANASDAQHealthcare● Active
$9.96
$-0.35(-3.39%)
Market Cap$869980811
P/E Ratio
52W High$36.259
52W Low$3.89
Overview

Olema Pharmaceuticals, Inc. (OLMA) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · OLMA · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-2.02olma eps ttm · olma earnings per shareEarnings history
PE Ratio (TTM)olma pe ratio ttm · olma price to earningsPE Ratio deep dive
Revenue (TTM)0.00olma revenue ttm · olma annual revenueFull revenue history
Dividend YieldNo Dividenddoes olma pay dividends · olma dividend yieldDividend history
Shares Outstanding87.0Molma shares outstanding · olma floatShares outstanding history
Next EarningsAug 10, 2026Est.olma earnings date · olma next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
olema pharmaceuticals, inc. revenue · olma revenue 2025
FY 2025Net Income-$162.5M▼ 25.47% YoY
202320242025
olema pharmaceuticals, inc. net income · olma profit 2025
FY 2025EPS$-1.87▲ +15.00% YoY
202320242025
olma eps · olema pharmaceuticals, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$185.2MEPS: $-2.02View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy8 analystsis olma a buy · olma analyst rating
Strong Buy
0
Buy
8
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$35.00Low
$9.96Current
$41.88Avg Target320.48% upside
$48.00High
olma price target · olma 12 month forecast

Total: 8 · Buy rate: 100.0%

The OLMA analyst consensus is Buy, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month price target is $41.88, representing +320.48% upside from the current price of $9.96.

Stock Performance

Full History
1D-3.46%
1W-3.28%
1M-30.81%
3M-52.16%
YTD-58.76%
1Y+135.39%
5Y-63.22%

About Olema Pharmaceuticals, Inc.

CEOSean Bohen
IPO DateNov 19, 2020
Employees96
CountryUS
Websiteolema.com

Olema Pharmaceuticals, Inc. a biopharmaceutical enterprise in the clinical development stage, is dedicated to discovering, advancing, and commercializing therapeutic solutions for women's oncology. H…

what is olema pharmaceuticals, inc. · olma stock overview · olema pharmaceuticals, inc. company profile · who is olema pharmaceuticals, inc. ceo · olma NASDAQ · olema pharmaceuticals, inc. headquarters · olema pharmaceuticals, inc. business segments

About Stock Overview & Key Data

Olema Pharmaceuticals, Inc. (OLMA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 19, 2020. As of the latest trading session, OLMA stock price is $9.96, with a market capitalization of $870.0M. The stock has returned +135.39% over the past 12 months and -58.76% year-to-date.

According to 8 Wall Street analysts, the consensus rating for Olema Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $41.88. In fiscal year 2025, Olema Pharmaceuticals, Inc. reported revenue of — and net income of -$162.5M. For detailed data — including Olema Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Olema Pharmaceuticals, Inc. (OLMA) stock price is $9.96. The stock is traded on NASDAQ under the ticker symbol OLMA. The 52-week range is $3.89 – $36.26.

OLMA stock priceOLMA quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice